CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ritonavir

利托那韦 杂质对照品Ritonavir Impurities

EP51 个杂质条目51 impurity entries

本页汇总 利托那韦 的 51 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 51 impurity reference standards of Ritonavir with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 利托那韦(Ritonavir)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method
    Journal of chromatographic science · 2018 · Mantripragada MKVVN et al.  ·  PMID 29300835  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir
    Journal of pharmaceutical and biomedical analysis · 2014 · Venugopal N et al.  ·  PMID 24366213  ·  DOI
  3. 杂质研究Impurity studiesLow level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization
    Journal of pharmaceutical and biomedical analysis · 2011 · Kakadiya PR et al.  ·  PMID 21353429  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisStereoselective hydroazidation of amino enones: synthesis of the ritonavir/lopinavir core
    Organic letters · 2006 · Adamo I et al.  ·  PMID 16381565  ·  DOI
  • 合成方法SynthesisEpoxyalcohol route to hydroxyethylene dipeptide isosteres. Stereodivergent synthesis of the diamino alcohol core of ritonavir and its C-2 epimer
    The Journal of organic chemistry · 2002 · Benedetti F et al.  ·  PMID 12444650  ·  DOI

利托那韦 —— 原料药与杂质对照品Ritonavir — drug substance & impurities

共 52 个条目(含原料药本体)52 items incl. the drug substance
Ritonavir structure
EP原料药 APIAPI
利托那韦Ritonavir
Ritonavir
CAS No.155213-67-5
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 1 (Ritonavir EP Impurity A) structure
EPA
利托那韦杂质1 (利托那韦EP杂质A)Ritonavir Impurity 1 (Ritonavir EP Impurity A)
Ritonavir Impurity 1 (Ritonavir EP Impurity A)
CAS No.154212-61-0
Chemical FormulaC14H23N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 1 Lithium Salt (Ritonavir EP Impurity A Lithium Salt) structure
EPA
利托那韦杂质1 锂盐 (利托那韦EP杂质A 锂盐)Ritonavir Impurity 1 Lithium Salt (Ritonavir EP Impurity A Lithium Salt)
Ritonavir Impurity 1 Lithium Salt (Ritonavir EP Impurity A Lithium Salt)
CAS No.201409-23-6
Chemical FormulaC14H22LiN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 2 (Ritonavir EP Impurity B Hydrochloride) structure
EPB
利托那韦杂质2 (利托那韦EP杂质B 盐酸盐)Ritonavir Impurity 2 (Ritonavir EP Impurity B Hydrochloride)
Ritonavir Impurity 2 (Ritonavir EP Impurity B Hydrochloride)
CAS No.165315-97-9
Chemical FormulaC28H36N4O4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 3 (Ritonavir EP Impurity C) structure
EPC
利托那韦杂质3 (利托那韦EP杂质C)Ritonavir Impurity 3 (Ritonavir EP Impurity C)
Ritonavir Impurity 3 (Ritonavir EP Impurity C)
CAS No.1010808-43-1
Chemical FormulaC25H29N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 4 (Ritonavir EP Impurity D) structure
EPD
利托那韦杂质4 (利托那韦EP杂质D)Ritonavir Impurity 4 (Ritonavir EP Impurity D)
Ritonavir Impurity 4 (Ritonavir EP Impurity D)
CAS No.144142-33-6
Chemical FormulaC28H30N4O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 5 (Ritonavir EP Impurity E) structure
EPE
利托那韦杂质5 (利托那韦EP杂质E)Ritonavir Impurity 5 (Ritonavir EP Impurity E)
Ritonavir Impurity 5 (Ritonavir EP Impurity E)
CAS No.176655-56-4
Chemical FormulaC37H48N6O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 6 (Ritonavir EP Impurity F) structure
EPF
利托那韦杂质6 (利托那韦EP杂质F)Ritonavir Impurity 6 (Ritonavir EP Impurity F)
Ritonavir Impurity 6 (Ritonavir EP Impurity F)
CAS No.1010809-61-6
Chemical FormulaC29H34N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 7 (Ritonavir EP Impurity G) structure
EPG
利托那韦杂质7 (利托那韦EP杂质G)Ritonavir Impurity 7 (Ritonavir EP Impurity G)
Ritonavir Impurity 7 (Ritonavir EP Impurity G)
CAS No.2034136-66-6
Chemical FormulaC37H48N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 8 (Ritonavir EP Impurity H) structure
EPH
利托那韦杂质8 (利托那韦EP杂质H)Ritonavir Impurity 8 (Ritonavir EP Impurity H)
Ritonavir Impurity 8 (Ritonavir EP Impurity H)
CAS No.1010809-43-4
Chemical FormulaC30H32N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 9 (Ritonavir EP Impurity I) structure
EPI
利托那韦杂质9 (利托那韦EP杂质I)Ritonavir Impurity 9 (Ritonavir EP Impurity I)
Ritonavir Impurity 9 (Ritonavir EP Impurity I)
CAS No.165315-26-4
Chemical FormulaC36H46N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 10 (Ritonavir EP Impurity J) structure
EPJ
利托那韦杂质10 (利托那韦EP杂质J)Ritonavir Impurity 10 (Ritonavir EP Impurity J)
Ritonavir Impurity 10 (Ritonavir EP Impurity J)
CAS No.162849-95-8
Chemical FormulaC28H35N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 11 (Ritonavir EP Impurity K) structure
EPK
利托那韦杂质11 (利托那韦EP杂质K)Ritonavir Impurity 11 (Ritonavir EP Impurity K)
Ritonavir Impurity 11 (Ritonavir EP Impurity K)
CAS No.1010809-39-8
Chemical FormulaC28H35N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 12 (Ritonavir EP Impurity L) structure
EPL
利托那韦杂质12 (利托那韦EP杂质L)Ritonavir Impurity 12 (Ritonavir EP Impurity L)
Ritonavir Impurity 12 (Ritonavir EP Impurity L)
CAS No.256328-82-2
Chemical FormulaC33H43N5O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 14 (Ritonavir EP Impurity N) structure
EPN
利托那韦杂质14 (利托那韦EP杂质N)Ritonavir Impurity 14 (Ritonavir EP Impurity N)
Ritonavir Impurity 14 (Ritonavir EP Impurity N)
CAS No.202816-62-4
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 15 (Ritonavir EP Impurity O) structure
EPO
利托那韦杂质15 (利托那韦EP杂质O)Ritonavir Impurity 15 (Ritonavir EP Impurity O)
Ritonavir Impurity 15 (Ritonavir EP Impurity O)
CAS No.1414933-81-5
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 17 (Ritonavir EP Impurity Q) structure
EPQ
利托那韦杂质17 (利托那韦EP杂质Q)Ritonavir Impurity 17 (Ritonavir EP Impurity Q)
Ritonavir Impurity 17 (Ritonavir EP Impurity Q)
CAS No.1414933-82-6
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 18 (Ritonavir EP Impurity R) structure
EPR
利托那韦杂质18 (利托那韦EP杂质R)Ritonavir Impurity 18 (Ritonavir EP Impurity R)
Ritonavir Impurity 18 (Ritonavir EP Impurity R)
CAS No.1414933-80-4
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 19 (Ritonavir EP Impurity S) structure
EPS
利托那韦杂质19 (利托那韦EP杂质S)Ritonavir Impurity 19 (Ritonavir EP Impurity S)
Ritonavir Impurity 19 (Ritonavir EP Impurity S)
CAS No.2084828-53-3
Chemical FormulaC52H61N7O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 20 (Ritonavir EP Impurity T) structure
EPT
利托那韦杂质20 (利托那韦EP杂质T)Ritonavir Impurity 20 (Ritonavir EP Impurity T)
Ritonavir Impurity 20 (Ritonavir EP Impurity T)
CAS No.869368-48-9
Chemical FormulaC46H66N8O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 1-d6 (Ritonavir EP Impurity A-d6) structure
EPA-D6
利托那韦杂质1-d6 (利托那韦EP杂质A-d6)Ritonavir Impurity 1-d6 (Ritonavir EP Impurity A-d6)
Ritonavir Impurity 1-d6 (Ritonavir EP Impurity A-d6)
CAS No.1331906-73-0
Chemical FormulaC14H17D6N3O3S
Purity>95%询价On request
Desthiazolylmethyloxycarbonyl Ritonavir-d6 structure
—
去噻唑基甲氧羰基利托那韦-d6Desthiazolylmethyloxycarbonyl Ritonavir-d6
Desthiazolylmethyloxycarbonyl Ritonavir-d6
CAS No.1217772-02-5
Chemical FormulaC32H39D6N5O3S
Purity>95%询价On request
Ritonavir Impurity 27(Desthiazolylmethyloxycarbonyl Ritonavir) structure
27
利托那韦杂质27(去噻唑基甲氧羰基利托那韦)Ritonavir Impurity 27(Desthiazolylmethyloxycarbonyl Ritonavir)
Ritonavir Impurity 27(Desthiazolylmethyloxycarbonyl Ritonavir)
CAS No.176655-55-3
Chemical FormulaC32H45N5O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 28 structure
28
利托那韦杂质28Ritonavir Impurity 28
Ritonavir Impurity 28
CAS No.176655-57-5
Chemical FormulaC30H39N5O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 29 structure
29
利托那韦杂质29Ritonavir Impurity 29
Ritonavir Impurity 29
CAS No.959351-57-6
Chemical FormulaC31H41N5O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 30 structure
30
利托那韦杂质30Ritonavir Impurity 30
Ritonavir Impurity 30
CAS No.190649-36-6
Chemical FormulaC43H56N6O11S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 31 structure
31
利托那韦杂质31Ritonavir Impurity 31
Ritonavir Impurity 31
CAS No.144164-11-4
Chemical FormulaC23H27N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 32 structure
32
利托那韦杂质32Ritonavir Impurity 32
Ritonavir Impurity 32
CAS No.183388-64-9
Chemical FormulaC23H32N2O3·C4H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 33 Monomer structure
33
利托那韦杂质33 单体Ritonavir Impurity 33 Monomer
Ritonavir Impurity 33 Monomer
CAS No.144163-97-3
Chemical FormulaC11H8N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 33 structure
33
利托那韦杂质33Ritonavir Impurity 33
Ritonavir Impurity 33
CAS No.154212-59-6
Chemical FormulaC11H8N2O5S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 34 structure
34
利托那韦杂质34Ritonavir Impurity 34
Ritonavir Impurity 34
CAS No.38585-74-9
Chemical FormulaC4H5NOS
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 35 structure
35
利托那韦杂质35Ritonavir Impurity 35
Ritonavir Impurity 35
CAS No.259188-38-0
Chemical FormulaC23H41N5O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 36 structure
36
利托那韦杂质36Ritonavir Impurity 36
Ritonavir Impurity 36
CAS No.156732-12-6
Chemical FormulaC25H24N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 37 structure
37
利托那韦杂质37Ritonavir Impurity 37
Ritonavir Impurity 37
CAS No.2454100-44-6
Chemical FormulaC32H32N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 38 structure
38
利托那韦杂质38Ritonavir Impurity 38
Ritonavir Impurity 38
CAS No.156732-15-9
Chemical FormulaC32H36N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 39 structure
39
利托那韦杂质39Ritonavir Impurity 39
Ritonavir Impurity 39
CAS No.162849-93-6
Chemical FormulaC37H44N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 47 structure
47
利托那韦杂质47Ritonavir Impurity 47
Ritonavir Impurity 47
CAS No.165316-09-6
Chemical FormulaC13H21N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 55 structure
55
利托那韦杂质55Ritonavir Impurity 55
Ritonavir Impurity 55
CAS No.154248-99-4
Chemical FormulaC15H25N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 56 structure
56
利托那韦杂质56Ritonavir Impurity 56
Ritonavir Impurity 56
CAS No.1356922-07-0
Chemical FormulaC24H34N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 59 structure
59
利托那韦杂质59Ritonavir Impurity 59
Ritonavir Impurity 59
CAS No.156732-13-7
Chemical FormulaC32H32N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 60 structure
60
利托那韦杂质60Ritonavir Impurity 60
Ritonavir Impurity 60
CAS No.220887-32-1
Chemical FormulaC32H32N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 61 Dihydrochloride structure
61
利托那韦杂质61 双盐酸盐Ritonavir Impurity 61 Dihydrochloride
Ritonavir Impurity 61 Dihydrochloride
CAS No.1185167-55-8
Chemical FormulaC8H14N2S·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 61 structure
61
利托那韦杂质61Ritonavir Impurity 61
Ritonavir Impurity 61
CAS No.154212-60-9
Chemical FormulaC8H14N2S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 62 structure
62
利托那韦杂质62Ritonavir Impurity 62
Ritonavir Impurity 62
CAS No.105315-40-0
Chemical FormulaC4H2Cl3NS
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 63 structure
63
利托那韦杂质63Ritonavir Impurity 63
Ritonavir Impurity 63
CAS No.1283151-18-7
Chemical FormulaC23H32N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 64 structure
64
利托那韦杂质64Ritonavir Impurity 64
Ritonavir Impurity 64
CAS No.1010809-54-7
Chemical FormulaC32H42N4O8S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 65 structure
65
利托那韦杂质65Ritonavir Impurity 65
Ritonavir Impurity 65
CAS No.1010809-50-3
Chemical FormulaC32H42N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 67 structure
67
利托那韦杂质67Ritonavir Impurity 67
Ritonavir Impurity 67
CAS No.2872582-94-8
Chemical FormulaC37H48N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 68 (N-Nitroso Ritonavir Impurity 61) structure
68
利托那韦杂质68 (N-亚硝基利托那韦杂质61)Ritonavir Impurity 68 (N-Nitroso Ritonavir Impurity 61)
Ritonavir Impurity 68 (N-Nitroso Ritonavir Impurity 61)
CAS No.3079775-24-6
Chemical FormulaC8H13N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 69 structure
69
利托那韦杂质69Ritonavir Impurity 69
Ritonavir Impurity 69
CAS No.165315-44-6
Chemical FormulaC15H25N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 70 structure
70
利托那韦杂质70Ritonavir Impurity 70
Ritonavir Impurity 70
CAS No.1156504-13-0
Chemical FormulaC37H46N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ritonavir Impurity 55-d6 structure
55-D6
利托那韦杂质55-d6Ritonavir Impurity 55-d6
Ritonavir Impurity 55-d6
CAS No.1331897-89-2
Chemical FormulaC15H19D6N3O3S
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

利托那韦 —— 研究文献与合成路线Ritonavir — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 利托那韦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ritonavir. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. LC-MS/MS studies of ritonavir and its forced degradation products
    Rao RN, Ramachandra B, Vali RM, et al. · Journal of pharmaceutical and biomedical analysis · 2010 · 被引 27cited 27
  2. Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment
    Yassin MG, Roshdy A, Marie AA · Scientific reports · 2025 · 被引 1cited 1
  3. Impact of Polymer Type on Thermal Degradation of Amorphous Solid Dispersions Containing Ritonavir
    Alvarenga BR, Moseson DE, Carneiro RL, et al. · Molecular pharmaceutics · 2022 · 被引 13cited 13
  4. Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir
    Venugopal N, Vijaya Bhaskar Reddy A, Madhavi G · Journal of pharmaceutical and biomedical analysis · 2014 · 被引 14cited 14
  5. Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization
    Kakadiya PR, Reddy BP, Singh V, et al. · Journal of pharmaceutical and biomedical analysis · 2011 · 被引 12cited 12
  6. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method
    Mantripragada MKVVN, Rao SV, Nutulapati VVS, et al. · Journal of chromatographic science · 2018 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF FORM I AND FORM II OF RITONAVIR
    SHARMA MUKESH KUMAR, KHANDURI CHANDRA HAS, SINGH PANKAJ KUMAR, SACHDEVA YOGINDER PAL · 公开号 WO2008041176WO2008041176 · 2008
  2. PROCESS FOR THE PREPARATION OF FORM I AND FORM II OF RITONAVIR
    SHARMA MUKESH KUMAR, KHANDURI CHANDRA HAS, SINGH PANKAJ KUMAR, SACHDEVA YOGINDER PAL · 公开号 US2010099885US2010099885 · 2010
  3. PROCESS FOR THE PREPARATION OF FORM I AND FORM II OF RITONAVIR
    SHARMA MUKESH KUMAR, KHANDURI CHANDRA HAS, SINGH PANKAJ KUMAR, SACHDEVA YOGINDER PAL · 公开号 EP2077903EP2077903 · 2009
  4. Process for synthesizing ritonavir
    JIN LIREN, XU ZHIJIE, JIANG HONGPING · 公开号 CN1554647CN1554647 · 2004
  5. Processes for the Preparation of Stable Polymorphic Form I of Ritonavir
    SACHDEVA YOGINDER PAL, BOSE PROSENJIT · 公开号 US2008312300US2008312300 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

利托那韦 杂质谱研究要点Ritonavir — impurity profiling notes

下面这些是拿到 利托那韦 的 52 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 52 impurity entries for Ritonavir, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances